Triple
T22405065
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Working Group of Enforcement Officers |
E553858
|
entity |
| Predicate | collaboratesWith |
P37
|
FINISHED |
| Object | Heads of Medicines Agencies Management Group |
—
|
NE NERFINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Heads of Medicines Agencies Management Group | Statement: [Working Group of Enforcement Officers, collaboratesWith, Heads of Medicines Agencies Management Group]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Heads of Medicines Agencies Management Group Context triple: [Working Group of Enforcement Officers, collaboratesWith, Heads of Medicines Agencies Management Group]
-
A.
Heads of Medicines Agencies
chosen
Heads of Medicines Agencies is a European network of national medicines regulatory authorities that collaborates to coordinate and harmonize the regulation of medicinal products across EU and EEA member states.
-
B.
Management Board of the European Medicines Agency
The Management Board of the European Medicines Agency is the governing body that oversees the agency’s strategy, budget, and overall operations in regulating medicines within the European Union.
-
C.
WHO Collaborating Centre for Drug Statistics Methodology
The WHO Collaborating Centre for Drug Statistics Methodology is a specialized World Health Organization center responsible for developing and maintaining international standards for drug classification and consumption statistics, including the ATC/DDD system.
-
D.
Committee for Proprietary Medicinal Products
The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
-
E.
Committee for Medicinal Products for Human Use
The Committee for Medicinal Products for Human Use is the European Medicines Agency’s expert body responsible for evaluating and providing scientific opinions on the safety, quality, and efficacy of medicines for human use in the European Union.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e11e4da7048190b4387d422a9a0de5 |
completed | April 16, 2026, 5:37 p.m. |
| NER | Named-entity recognition | batch_69f158b739b88190a7f1f20fd1e9b188 |
completed | April 29, 2026, 1:02 a.m. |
Created at: April 16, 2026, 8:46 p.m.